Bishal Gyawali, Medical Oncologist and Assistant Professor at Queen’s University, shared on X:
“Very fascinating interview in Endpoints News with Janet Woodcock as she retires from the FDA.
However, I am not aware of any evidence for the claim that survival gains can largely be attributed to therapeutics. We actually discussed this in our eClinicalMedicine – The Lancet Discovery Science paper 2 years ago.”
Source: Bishal Gyawali/X